Orbimed Advisors - RESTORBIO INC ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of RESTORBIO INC
ValueSharesWeighting
Q2 2020$10,385,000
+108.7%
4,830,3870.0%0.15%
+73.8%
Q1 2020$4,975,000
-30.9%
4,830,3870.0%0.08%
-18.4%
Q4 2019$7,197,000
-83.1%
4,830,3870.0%0.10%
-87.3%
Q3 2019$42,701,000
-13.3%
4,830,3870.0%0.81%
+6.2%
Q2 2019$49,270,000
+49.6%
4,830,3870.0%0.76%
+49.6%
Q1 2019$32,943,000
-20.9%
4,830,3870.0%0.51%
-33.8%
Q4 2018$41,638,000
-43.1%
4,830,3870.0%0.77%
-12.6%
Q3 2018$73,132,000
+65.5%
4,830,3870.0%0.88%
+67.2%
Q2 2018$44,198,000
-4.5%
4,830,3870.0%0.53%
-8.2%
Q1 2018$46,275,0004,830,3870.57%
Other shareholders
RESTORBIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
AWH Capital, L.P. 105,000$226,0000.44%
Ikarian Capital, LLC 1,452,551$3,123,0000.25%
Anson Funds Management LP 387,817$834,0000.21%
Nantahala Capital Management 2,906,340$6,249,0000.19%
Orbimed Advisors 4,830,387$10,385,0000.15%
Strategic Wealth Investment Group, LLC 26,940$58,0000.06%
Artal Group S.A. 953,000$2,049,0000.06%
BEAM WEALTH ADVISORS, INC. 14,000$35,0000.04%
BRAVE ASSET MANAGEMENT INC 23,250$50,0000.03%
Edge Wealth Management LLC 53,137$114,0000.02%
View complete list of RESTORBIO INC shareholders